IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Viracta Therapeutics Inc

CUSIP: 92765F108 | 156 institutional holders

Quarters

Q4 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Motiv8 Investments LLC14
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Motiv8 Investments LLC
14$00.0%GrowthMediumPort St. Lucie, FL2026-02-13